A Randomized, Double-Blind, Placebo-Controlled, Two-Part Study in Parkinson's Disease Patients With Dyskinesia to Assess the Efficacy and Safety/Tolerability of Fixed Dose Combinations of JM-010 and Its Individual Components

Investigator: Olga Waln, MD

Study Coordinator: Yvonne Subhan

Status: Enrolling

ClinicalTrials.gov Number: NCT04377945

Phone: 346.238.9068

Protocol Number: PRO00028550


This is a two-part, double-blind, placebo-controlled, randomized, multicenter Phase 2 clinical trial of JM-010 in patients with Parkinson's Disease.
More to Explore